| 18 MARCH 2022 | ||
|---|---|---|
| 09:30 – 09:40 | Opening Ceremony | |
| Dr. Kerim Güler / Turkish Society of Internal Medicine Dr. Aleksandar Manolev / Macedonian Society of Internal Medicine Ambassador Hasan Mehmet Sekizkök / Ambassador of Türkiye to North Macedonia |
||
| 09:40 – 10:30 | Session 1 Chairs: Biljana Koleva, Mimoza Nikolovska Kotevska, Sedat Kiraz |
|
| 09:40 – 10:05 | Management of Diabetes in Rheumatological Diseases | Kubilay Ükinç |
| 10:05 – 10:30 | Management of Hypertension in Rheumatological Diseases | Biljana Koleva |
| 10:30 10:45 | COFFEE BREAK | |
| 10:45 – 12:00 | Session 2 Chairs: İhsan Ertenli, Snezana Percinkova Mishevska |
|
| 10:45 – 11:10 | What ACR Really Recommends with the 2021 RA Treatment Guideline in Contrast to 2019 EULAR | Nilüfer Alpay Kanıtez |
| 11:10 – 11:35 | Can We Reach Comprehensive Disease Control in Rheumatoid Arthritis? | Abdulsamet Erden |
| 11:35 – 12:00 | Managing Extra-Articular Manifestations in Rheumatoid Arthritis | Vedat Gerdan |
| 12:00 – 13:15 | Lunch | |
| 13:15 – 14:05 | Session 3 Chairs: Vedat Hamuryudan, Ljubinka Damjanovska Krstik |
|
| 13:15 – 13:40 | How Do Patients with Non‐Radiographic Axial Spondylarthritis Differ from Patients with Ankylosing Spondylitis? | Pamir Atagündüz |
| 13:40 – 14:05 | Atlanto-axial Subluxation As Problem In Patients with Rheumatoid Arthritis | Snezana Percinkova Mishevska |
| 14:05 – 15:20 | Session 4 Chairs: Filip Guchev, Isık Atagunduz, Eftal Yucel |
|
| 14:05 – 14:30 | Safety Update for Biologics | Zevcet Yılmaz |
| 14:30 – 14:55 | Treatment and Follow-up Approach to Pregnant Rheumatoid Arthritis Patients: Update on Pregnancy, Lactation and Fertility | Dilek Solmaz |
| 14:55 – 15:20 | Novel Antibodies in RA | Ljubinka Damjanovska Krstik |
| 15:20 – 15:40 | COFFEE BREAK | |
| 15:40 – 16:05 | Session 5 Chairs: Mimoza Nikolovska Kotevska, Timuçin Kaşifoğlu |
|
| 15:40 – 16:05 | Update on the Management of Colchicine Resistant Familial Mediterranean Fever | Aysenur Pac Kısaarslan |
| 16:05 – 16:30 | Prevention and Treatment of Glucocorticoid-Induced Osteoporosis | İlknur Aktaş |
| 16:30 – 17:10 | Session 6: Case Presentations I Chair:Adem Kucuk |
|
| – Treatment of Spondylitis Ankylosans with biologis, Sanja Petrova – Significance of C-reactive Protein in Rheumatoid Arthritis, Lindita Xhemaili Jakupi – Jaw necrosis as adverse effect of Denosumab in patient with RA, Emilija Sandevska – Efficacy of Exclusive Enteral Nutrition and weekly adalimumab combination in Crohn’s patients with fibroinflammatory stenosis, Salih Tokmak – Ankylosing Spondylitis patient with Bilateral Optic Neuritis, Zeynel Abidin Akar |
||
| 19 MARCH 2022 | ||
| 09:00 – 10:15 | Session 7 Chairs: Bashkim Osmani, Ediz Dalkılıç |
|
| 09:00 – 09:25 | Pain and Consequences for SpA Patients | Servet Akar |
| 09:25 – 09:50 | Emerging Therapies in Psoriatic Arthritis | Cemal Bes |
| 09:50 – 10:15 | Musculosceletal US in Seronegative Arthropaties | Bashkim Osmani |
| 10:15 – 10:30 | COFFEE BREAK | |
| 10:30 – 12:00 | Session 8 Chairs: Dubravka Antova, Omer Kuru |
|
| 10:30 – 10:55 | COVID-19 Pandemia: Where we are now? | Serhat Ünal |
| 10:55 – 11:20 | Are all JAK Inhibitors the Same in IBD? | Nalan Gulsen Unal |
| 11:20 – 11:45 | Does Interleukin-23 (IL-23) Inhibitors Change the Course of Treatment in Psoriasis and Psoriatic Arthritis? | Yasemin Yalcinkaya |
| 11:45 – 12:10 | When to Escalate and Taper the Biologics? | Filip Guchev |
| 12:10 – 13:15 | Lunch | |
| 13:15 – 14:30 | Session 9 Chairs: Serdal Uğurlu, Dubravka Antova |
|
| 13:15 – 13:40 | How To Treat Vascular Involvement in Bechet’s Disease | Haner Direskeneli |
| 13:40 – 14:05 | How to Treat Intestinal Manifestations of Bechet’s Disease | Taylan Kav |
| 14:05 – 14:30 | Treatment of Bechet’s Disease Related Non-Infectious Uveitis | Esra Kardes |
| 14:30 – 15:45 | Session 10 Chairs: Ayse Cefle, Hakan Erdem |
|
| 14:30 – 14:55 | Management of COVID 19 in Patients with Rheumatic Diseases | Berkan Armagan |
| 14:55 – 15:20 | Risk of Tuberculosis Among Patients Using Biologic Therapies | Berna Yurttas |
| 15:20 – 15:45 | Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution and Perspective | Elena Perkova |
| 15:45 – 16:10 | COFFEE BREAK | |
| 16:10 – 17:25 | Session 11 Chairs: Aleksandar Manolev, Figen Tarhan, Bashkim Osmani |
|
| 16:10 – 16:35 | Interdisciplinary Approach in mesenteric presentation of Vasculitis | Aleksandar Manolev |
| 16:35 – 16:50 | Update in the Treatment of Takayasu Arteritis | Fatma Alibaz Öner |
| 16:50 – 17:15 | Update on Antiphospholipid Antibody Syndrome | Emre Bilgin |
| 17:15 – 18:25 | Session 12: Case Presentations II Chairs: Hakan Emmungil, Nesrin Şen |
|
| – Takayasu areritis rapped into multi-symptomatic syndrome, Aleksandar Manolev – Vasculitis pigmentosa chronica, Dejan Spasovski – Familial Mediterranean Fever Erythematous Lesions On The Abdominal İnjection Sites With Anakinra, Yasemin Kara – The prevalence of gastric precancerous lesions and helicobacter pylori, a singlecenter data, Fatih Eren – Antisynthetase Syndrome, Vlatko Karanfilovski |
||